Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on Resignation of FDA Commissioner…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE…
Learn more
BIO Launches “The Fight of Our Lives,” a National…
WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of ​​The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them…
Learn more
BIO Statement on the Section 232 Pharmaceutical…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on Section 232 Pharmaceutical Proclamation.“A thriving American biotechnology ecosystem is essential to…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
National and Local Companies Form New Mexico Clean Fuels Coalition to Support Diversification of State's Economy
March 5, 2021
Albuquerque, NM (March 5, 2021) – In response to New Mexico’s proposed Clean Fuel Standard legislation, 21 national and New Mexico-based companies and organizations formed the New Mexico Clean Fuel Coalition to support the state’s efforts to…
Supercharging Marketing—the Mission for New Chief Marketing Officer at BIO
January 28, 2021
Washington, DC – The Biotechnology Innovation Organization (BIO) has appointed Melissa von Stauffenberg as Chief Marketing Officer, effective February 1, 2021. The newly created position emerged from a recent reorganization aimed at driving a…
New “100 Days of Innovation” Blueprint Outlines Priorities To End the Pandemic, Build American Resiliency
January 27, 2021
As Congress and the new President lay out their aggressive “100 Day Plans,” The Biotechnology Innovation Organization (BIO) today released a new blueprint highlighting goals to strengthen America’s innovation ecosystem, end the COVID-19 pandemic,…
New Criteria Set for Political Contributions from BIO
January 26, 2021
The Biotechnology Innovation Organization announced today that it will resume political giving under new criteria for political leaders seeking campaign assistance. Shortly after the violent demonstration three weeks ago at the US Capitol BIO…
BIO Welcomes U.S. Involvement in COVAX, ACT Accelerator Programs
January 21, 2021
The Biden administration just announced its intent for the United States to join the COVAX vaccine facility, which aims to deliver COVID-19 vaccines to poor and under-developed countries. Dr. Michelle McMurry-Heath, president and CEO of the…
BIO and LCFC Support New Mexico Governor's Vision to Address Climate Change Through Clean Fuel Standard
January 20, 2021
Washington, D.C. (January 20, 2021) — The BiotechnologyInnovation Organization (BIO) and the Low Carbon Fuels Coalition (LCFC) today released the following statement in support of New Mexico Governor Michelle Lujan Grisham’s inclusion of a…
BIO Condemns Trump Administration's Last-ditch Effort To Strip Critical Medicare Part D Protections
January 20, 2021
In his last day in office, former President Donald Trump proposed a sweeping change to Medicare’s “Part D” drug benefit. Billed as a demonstration project through the Centers for Medicare and Medicaid Innovation (CMMI), this new policy would allow…
BIO Congratulates President Biden and Vice President Harris on "Historic Inauguration"
January 20, 2021
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO) made the following remarks after President Joe Biden and Vice President Kamala Harris were sworn into office:  “On behalf of the Biotechnology…
Biotechnology’s Leading Trade Group Restructures for the Future
January 19, 2021
Washington, DC –  The Biotechnology Innovation Organization (BIO), which announced its transition to a new CEO in June to Dr. Michelle McMurry-Heath, is announcing a new leadership team and organizational structure that promises to provide long…
BIO Applauds Incoming Administration's Decision Elevating Key White House Science Post to Cabinet-level Agency
January 16, 2021
President-elect Joe Biden announced on Friday a plan to make the White House Office of Science and Technology Policy a Cabinet-level agency. Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), made the…